Highlights from the latest articles in diabetes pharmacogenomics

Pharmacogenomics. 2012 Feb;13(3):261-4. doi: 10.2217/pgs.11.182.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cardiovascular Diseases / genetics*
  • Coronary Artery Disease / enzymology*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / enzymology*
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetic Angiopathies / enzymology*
  • Edema / chemically induced*
  • Female
  • Genetic Association Studies*
  • Genetic Variation / genetics*
  • Glucose Intolerance / genetics*
  • Glutathione Peroxidase / genetics*
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / blood*
  • Male
  • Metformin / blood*
  • NAD(P)H Dehydrogenase (Quinone) / genetics*
  • Receptors, Adiponectin / genetics*
  • Thiazolidinediones / adverse effects*

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Receptors, Adiponectin
  • Thiazolidinediones
  • Metformin
  • Glutathione Peroxidase
  • NAD(P)H Dehydrogenase (Quinone)